Gabriela Ispas Selected Research

2- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- ol

1/2015

Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriela Ispas Research Topics

Disease

3	Human Influenza (Influenza) 01/2022 - 12/2014
2	Infections 01/2015 - 01/2013

Drug/Important Bio-Agent (IBA)

2	Oxygen (Dioxygen)IBA 01/2022 - 11/2021
2	Antiviral Agents (Antivirals)IBA 12/2014 - 01/2013
1	SteroidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Antitussive Agents (Antitussives)FDA Link 01/2022
1	Bronchodilator Agents (Bronchodilators)IBA 01/2022
1	2- (6- ((2- (3- hydroxypropyl)- 5- methylphenylamino)methyl)- 2- (3- morpholin- 4- ylpropylamino)benzoimidazol- 1- ylmethyl)- 6- methylpyridin- 3- olIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 12/2014

Therapy/Procedure

2	Length of Stay 01/2022 - 11/2021
1	Patient Readmission 01/2022